gynecologic cancers: ovarial cancer

Studies

ID Name Stage Status
HJOCS Hannover-Jena Ovarian Cancer Study various active
AGO-OVAR OP.4 Chemotherapy +/- tumordebulking in recurrent ovarian cancer (DESKTOP III) various active
AGO-Gyn 8 AGO-Gyn 8 various active
AGO-Ovar 17 Bevacizumab Ovarian Optimal Standard Treatment (BOOST) various active
AGO Ovar 2.16 MITO 8 various paused
EFC6521 AVE5026 for prophylaxis of thrombosis in tumor patients (SAVE-ONCO) various closed
3104000 various closed
AEZS-108-040 Antitumorale Wirksamkeit und Verträglichkeit von AEZS-108 (AGO-Gyn 5) various closed
AGO-OVAR OP.3 Lymphadenectomy in Ovarian Neoplasms (LION) various closed
110655 Pazopanib vs. Placebo (AGO-Ovar 16) metastatic
 closed
D4320C00036 Carboplatin/Paclitaxel ± ZD4054 (AGO-Ovar 2.14) various closed
D4200C00083 Vandetanib + peglioposomal doxorubicin (AGO-Ovar 2.13) various closed
AGO-Ovar 2.13 various closed
TRINOVA-2 TRial IN OVArian Cancer-2 various closed